Cal Robinson

SickKids Peds Nephrology | PhD student | Toronto 🇨🇦 | Aspiring clinician-scientist | Adaptive clinical trials, trial emulation, and health admin data

[Pediatric Nephrology @Ped_Neph]

Central venous catheter–related bloodstream infections (CRBSI) are common in children receiving hemodialysis & cause significant morbidity & healthcare costs. Read this Original Article on use of 4% tetrasodium EDTA (KiteLock™) to prevent CRBSI.
https://t.co/67IF3Zsh3l

[Pediatric Nephrology @Ped_Neph]

Steroid-sparing immunosuppression is used in 50% of children w/nephrotic syndrome, but rates & predictors of prolonged remission after cyclophosphamide & tacrolimus are uncertain. Read this Original Article for more.
https://t.co/awBN89O0zU

[Cal Robinson @KidneyCal]

I have made the jump over to BlueSky - follow me there at the same handle @KidneyCal

https://t.co/0kHQ68F1QD

[JASN_News @JASN_News]

AKI affects a growing number of children and neonates and is associated with high morbidity, mortality, and health care expenditure. In this issue of JASN, Robinson et al. present the findings of a large cohort study on the long-term outcomes of AKI in hospitalized children who did not require acute KRT. In this editorial, @KidneyCathy and @emjsee argue that these findings confirm the poor long-term outcomes of AKI in hospitalized children who do not require acute KRT. https://t.co/Ch6cFtKvFk
@MCRI_for_kids
@AU_RMH

[Cal Robinson @KidneyCal]

How can simulation be used to improve the design adaptive clinical trials? Read our review article just published in @JASN_News to find out!

Big thanks to co-authors @DrRulanParekh @douyang3 @efan75 @BrianCuthberts8 and Anna Heath.

https://t.co/N4fEpJ9vJH

[Edgar V. Lerma 🇵🇭 @edgarvlermamd]

Long-Term Kidney Outcomes after Pediatric AKI ca. 2024 from @JASN_News
#Nephpearls #KidneyWk #BestofJASN
#VisualAbstract by @nikkonephro

👉 https://t.co/cGNGutIOOA

[Cal Robinson @KidneyCal]

Article link: https://t.co/bzi57wFkEb

[Cal Robinson @KidneyCal]

Great to see our pediatric AKI long-term outcomes study highlighted in the Best of ASN Journals session at #ASNKids24 #ASN24 @ChanchlaniRahul

[Cal Robinson @KidneyCal]

Amazing to see a childhood nephrotic syndrome RCT in the #ASNKids24 ⁦@ASNKidney⁩ late breaking trials session! So exciting to see RCTs starting to emerge to improve treatment for these children

[Wendy Bravo, MD, MSCE @WendyHsiaoMD]

Excellent poster by Cal Robinson et al on a target trial emulation of cyclophosphamide vs CNIs in #nephroticsyndrome ! #ASNKids24 @ASPNeph @ASNKidney

[Cal Robinson @KidneyCal]

Come visit our posters today at #ASN2024 #ASNKIDS24 @ASNKidney.

PO-720: Comparative Effectiveness of Cyclophosphamide and Calcineurin Inhibitors in Childhood Nephrotic Syndrome

PO-386: Health Care Resource Utilization and Costs Associated with Childhood Hypertension

[JASN_News @JASN_News]

Using population-based health administrative databases, study investigators found that 1/3 of children with posterior urethral valves develop major adverse kidney events (death, kidney failure, or CKD) by early adulthood, compared with 1% of the general childhood population. https://t.co/OaWxl9B2yR

[American Society of Pediatric Nephrology @ASPNeph]

Long-Term Kidney Outcomes in Children with Posterior Urethral Valves
#PUV @JASN_News

https://t.co/am5kGQBX55

[Cal Robinson @KidneyCal]

Children with posterior urethral valves are at long-term risk of CKD, kidney failure, and hypertension.

One-third develop major adverse kidney events over median 16.6 year follow-up.

Kidney health surveillance into adulthood with improved transition planning is needed!

[Mandy @MandyRickardNP]

I am thrilled to share our newest paper about long term outcomes in #PUV patients using @ICESOntario data, out today in @JASN_News! https://t.co/kbIBkwfzEY
Thanks for the great collaboration @KidneyCal @about__juliane @TimVanMieghem @JoanaRosaP @ChanchlaniRahul @ArmandoJLorenzo

[American Society of Pediatric Nephrology @ASPNeph]

Long-Term Kidney Outcomes after Pediatric Acute Kidney Injury
#AKI
https://t.co/ggqo1VOn52
@JASN_News

[IMPaCT @IMPaCTrials]

Meet IMPaCT Fellow @KidneyCal ! Through his research, Cal aspires to advance the evidence-based treatment of pediatric kidney diseases, prevent adverse long-term outcomes, and minimize disease burden.

Learn more about Cal’s project here:
https://t.co/jFeuOHImj1

[IMPaCT @IMPaCTrials]

Interested in learning how to design and operate clinical trials for pregnant people and kids? 🤰👶🧒
Apply for an IMPaCT training award at https://t.co/XzwhwAMhgF!
Applications are open now, so don't miss out – submit by 5 PM CT on October 18, 2024!

[JASN_News @JASN_News]

Using population health databases from Ontario, Canada, investigators found that children surviving AKI without acute KRT were at higher long-term risk of CKD, long-term KRT, hypertension, and subsequent AKI compared with hospitalized children without AKI https://t.co/GyvRh3ZhhW

[JAMA Pediatrics @JAMAPediatrics]

Youth diagnosed with hypertension are at higher risk of long-term cardiovascular disease, justifying improving blood pressure follow-up and control strategies among hypertensive youth. #PAS2024 https://t.co/6r84qZJAuH